Sale by Third Rock Ventures GP V, LP
18,572 shares · @ $40.05 · $743,753
Rapport Therapeutics, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $39.50
+0.0% in 1d after detection
Post-detection moves
1h
—
1d
+0.0%
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS